![Matthew Greenhawt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 393 470 $ au 31/08/2026
Mr. Matthew Greenhawt was previously employed as a Chief Medical Officer by Aquestive Therapeutics, Inc. and a Chief Medical Officer by Asthma & Allergy Foundation of America.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/03/2026 | 77 000 ( 0,06% ) | 393 470 $ | 31/08/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
Asthma & Allergy Foundation of America
 Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur Technique/Scientifique/R&D | 01/01/2026 |
| AQUESTIVE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
Asthma & Allergy Foundation of America
Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
